Attached files
| file | filename |
|---|---|
| EX-99.1 - EX-99.1 - WRIGHT MEDICAL GROUP INC | d688322dex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 10, 2014
WRIGHT MEDICAL GROUP, INC.
(Exact Name of Registrant as Specified in Charter)
| Delaware | 001-35823 | 13-4088127 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| 1023 Cherry Road Memphis, Tennessee |
38117 | |
| (Address of principal executive offices) | (Zip code) |
(901) 867-9971
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item 8.01 | Other Events. |
On March 10, 2014, Wright Medical Group, Inc. (the “Company”) issued a press release announcing it has reached an agreement with the Office of Device Evaluation (“ODE”) of the U.S. Food and Drug Administration under which ODE will accept a further amendment to the pre-market approval application for Augment® Bone Graft in lieu of proceeding with the Dispute Resolution Panel that was scheduled for the week of May 19, 2014. The press release is filed as Exhibit 99.1 to this Form 8-K and is incorporated herein by reference.
Section 9 – Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits.
| (a) | Not applicable. |
| (b) | Not applicable. |
| (c) | Not applicable. |
(d) Exhibits
| 99.1 | Press Release of Wright Medical Group, Inc. dated March 10, 2014 | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| WRIGHT MEDICAL GROUP, INC. | ||||||
| Dated: March 10, 2014 | By: | /s/ Robert J. Palmisano | ||||
| Name: | Robert J. Palmisano | |||||
| Title: | President and Chief Executive Officer | |||||
EXHIBIT INDEX
| Exhibit Number |
Description | |
| 99.1 | Press Release of Wright Medical Group, Inc. dated March 10, 2014 | |